or poor-tolerated AFL Clinical history, other arrhythmias as atrial fibrillation (AF), data of echocardiography were collected. The patients were followed from 3 months up to 10 years.
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Impact of frailty and dependence on anticoagulant treatment prescription in older persons with atrial fibrillation
Colette Rio (1), François Lesaffre (1), Pierre Nazeyrollas (1), Jean Luc Novella (2), Sarah Ledon (1), Damien Metz (1) (1) CHU Reims Robert Debré, cardiologie, Reims, CHU Reims, gériatrie, Reims, France Introduction: Studies have documented the underuse of oral anticoagulant therapy (OAC) as stroke prophylaxis in older persons with history of atrial fibrillation (AF). Failure to prescribe OAC is often due to the perception by physicians of bleeding because of specific older people clinical factors.
We performed a prospective observational study in the University Hospital of Reims, whose aim was to evaluate the management of thromboembolic risk in older patients in everyday-life hospital practice and impact of frailty and dependence objective parameters.
Method: 150 AF patients over 75 years were consecutively included over a period of four months. Clinical and biological data, risk scores for bleeding (HASBLED) and thrombo-embolic events (CHADS and CHADSVASc) were computed. Several scores and parameters of assessment of autonomy and risk of falling were independently recorded: MMS (Mini-Mental Status), ADL (Activities of Daily Living) and IADL (Instrumental ADL).
Results: Mean age was 83±13 years (75 men). At discharge, 52.2% of patients were under OAC. Mean CHADS, CHADSVASc and HASBLED score were respectively 2,6±0,1, 4,6±0,1 and 2,3±0,1; all patients had a CHA DS VASc score ≥2 and 86% a CHADS ≥2. The HASBLED score was associated with non-prescription of anticoagulation (p=0.001), while none of the thrombo-embolic scores was significantly associated with prescription. Specific studied parameters are in table.
Conclusion:
In our study of everyday practice, there is an underuse of anticoagulation in the elderly compared to guidelines, mainly because the perception of the hemorrhagic risk prevails over the thrombo-embolic risk. Specific geriatric parameters could help to choose the appropriate therapy. Introduction: Age is a major thrombo-embolic risk factor in atrial fibrillation (AF), but also a risk factor for bleeding under oral anticoagulation therapy (OAC). However, it appears that older patients are inadequately treated with OAC.
The objective of our study was to evaluate the use of OAC in elderly patients hospitalised in a cardiology department according to current guidelines.
Method: Over a 4-month period, 142 patients over 75 years old with history of AF were included. Clinical and biological data were recorded, and risk scores for bleeding (HASBLED) and thrombo-embolic events (CHADS 2 and CHA 2 DS 2 VASc) were independently assessed after discharge. The differences between bleeding and thrombo-embolic risk were calculated for each patient. Patients with OAC at discharge and patients without OAC were compared.
Results: Mean age was 83±13 years (75 men). Mean CHADS, CHADS-
VASc and HASBLED scores were respectively 2,6±0,1, 4,6±0,1 and 2,3±0,1. According to CHADSVASc score and guidelines all of the patients were eligible for OAC. However 47.8% of patients were not under OAC. Those patients were older (84.6±0.6 vs. 81.8±0.5; p=0.001), predominantly female (66 vs. 35%; p=0.001) with a higher serum creatinine (127.3±7.3 vs. 106±6.3; p=0.03) and HASBLED score (2.7 vs. 2.16; p=0.001). OAC use was not associated with CHADS and CHADSVASc scores values.
Conclusion:
Our study in daily pratice confirms that OAC in older patients with AF are underused and that the bleeding risk may be over-rated and/or thrombo-embolic risk under-estimated. However, specific risk factors in older patients may not be included in currently used scores.
198
Patients over 75 years of age with and without atrial fibrillation: characteristics and differences in a hospital cohort of 357 patients Colette Rio (1), François Lesaffre (1), Pierre Nazeyrollas (1), Jean Luc Novella (2), Sophie Tassan-Mangina (1), Damien Metz (1) (1) CHU Reims Robert Debré, cardiologie, Reims, CHU Reims, gériatrie, Reims, France Introduction: Characteristics of patients with atrial fibrillation (AF) are well known, however the patients included in published studies are usually younger than patients encountered in daily practice in hospital. 
